Table 2 The associations between status of metabolic syndrome and cognitive function by Chi-square tests
|  | MoCA-T | AD-8 | Total n = 567 | ||||
|---|---|---|---|---|---|---|---|
Normal (MoCA-T ≥ 24) n = 394 (69.5%) n (%) | Cognitive impairment (MoCA-T < 24) n = 173 (30.5%) n (%) | p | Normal (AD-8 < 2) n = 494 (87.1%) n (%) | Cognitive impairment (AD-8 ≥ 2) 73 (12.9%) n (%) | p | ||
Abdominal obesity | Â | Â | Â | Â | Â | Â | Â |
 Normal | 228 (40.2) | 85 (15.0) | 0.05 | 272 (48.0) | 41 (7.2) | 0.86 | 313 (55.2) |
 Abnormal | 166 (29.3) | 88 (15.5) |  | 222 (39.2) | 32 (5.6) |  | 254 (44.8) |
Hypertension or on drug treatment | Â | Â | Â | Â | Â | Â | Â |
 Normal | 170 (30.0) | 60 (10.6) | 0.06 | 202 (35.6) | 28 (4.9) | 0.68 | 230 (40.6) |
 Abnormal | 224 (39.5) | 113 (19.9) |  | 292 (51.5) | 45 (7.9) |  | 337 (59.4) |
Hyperglycemia or on drug treatment | Â | Â | Â | Â | Â | Â | Â |
 Normal | 248 (43.7) | 104 (18.3) | 0.52 | 312 (55.0) | 40 (7.1) | 0.17 | 352 (62.1) |
 Abnormal | 146 (25.8) | 69 (12.2) |  | 182 (32.1) | 33 (5.8) |  | 215 (37.9) |
Hypertriglyceridemia or on drug treatment | Â | Â | Â | Â | Â | Â | Â |
 Normal | 295 (52.0) | 132 (23.3) | 0.72 | 377 (66.5) | 50 (8.8) | 0.15 | 427 (75.3) |
 Abnormal | 99 (17.5) | 41 (7.2) |  | 117 (20.6) | 23 (4.1) |  | 140 (24.7) |
Low HDL-C or on drug treatment | Â | Â | Â | Â | Â | Â | Â |
 Normal | 264 (46.6) | 111 (19.6) | 0.51 | 326 (57.5) | 49 (8.6) | 0.85 | 375 (66.1) |
 Abnormal | 130 (22.9) | 62 (10.9) |  | 168 (29.3) | 24 (4.2) |  | 192 (33.9) |
Metabolic syndrome | Â | Â | Â | Â | Â | Â | Â |
 No | 267 (47.1) | 106 (18.7) | 0.13 | 328 (57.9) | 45 (7.9) | 0.42 | 373 (65.8) |
 Yes | 127 (22.4) | 67 (11.8) |  | 166 (29.3) | 28 (4.9) |  | 194 (34.2) |